COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 31.27 CAD/shares as of 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2026-03-25
- 2025-09-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $31.27.
- 2025-03-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $30.98; Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed $30.43.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $25.77.
- 2024-09-30: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 $12.50.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 as first filed |
|---|---|---|
| 2025-09-30 | $31.27 6-K · filed 2025-11-12 | |
| 2025-03-31 | $30.98 6-K · filed 2025-08-14 | $30.43 6-K · filed 2025-05-13 |
| 2024-12-31 | $25.77 6-K · filed 2025-11-12 | |
| 2024-09-30 | $12.50 6-K · filed 2025-11-12 | |
| 2024-06-30 | $26.22 6-K · filed 2025-08-14 | |
| 2024-03-31 | $21.67 6-K · filed 2025-05-13 | $50.14 6-K · filed 2024-05-16 |
| 2023-12-31 | $20.74 6-K · filed 2025-11-12 | $12.51 20-F · filed 2024-03-27 |
| 2023-09-30 | $20.53 6-K · filed 2024-11-12 | $15.47 6-K · filed 2023-11-09 |
| 2023-06-30 | $20.46 6-K · filed 2024-08-13 | $15.98 6-K · filed 2023-08-09 |
| 2023-03-31 | $63.91 6-K · filed 2024-05-16 | $15.98 6-K · filed 2023-05-09 |
| 2022-12-31 | $28.37 20-F · filed 2025-04-09 | $20.05 20-F · filed 2023-03-23 |
| 2022-09-30 | $21.95 6-K · filed 2023-11-09 | |
| 2022-06-30 | $21.95 6-K · filed 2023-08-09 | $21.25 6-K/A · filed 2022-08-04 |
| 2022-03-31 | $21.95 6-K · filed 2023-05-09 | |
| 2021-12-31 | $23.73 20-F · filed 2025-04-09 | $22.00 6-K/A · filed 2022-08-04 |
| 2020-12-31 | $36.43 20-F/A · filed 2024-07-17 | $36.00 6-K/A · filed 2022-08-04 |
| 2019-12-31 | $90.25 20-F/A · filed 2024-02-15 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2025-12-31 | 31.27 CAD/shares 20-F · filed 2026-03-25 |
| 2024-12-31 | 25.77 CAD/shares 20-F · filed 2026-03-25 |
| 2023-12-31 | 28.40 CAD/shares 20-F · filed 2026-03-25 |
| 2022-12-31 | 28.37 CAD/shares 20-F · filed 2026-03-25 |
| 2019-12-31 | 22.80 CAD/shares 20-F/A · filed 2024-02-15 |